Formyl-peptide receptors revisited
- PMID: 12401407
- DOI: 10.1016/s1471-4906(02)02316-5
Formyl-peptide receptors revisited
Abstract
Leukocytes accumulate at sites of inflammation and microbial infection in direct response to locally produced chemotactic factors, which signal through specific G protein-coupled receptors. The first chemotactic factors to be structurally defined were the N-formyl peptides. Unlike other leukocyte chemoattractants, N-formyl peptides could originate from either an endogenous source, such as the mitochondrial proteins of ruptured host cells, or an exogenous source, such as the proteins of invading pathogens. This suggests that the formyl-peptide receptor (FPR) and its variant FPRL1 (FPR-like 1) are involved in host defense against bacterial infection and in the clearance of damaged cells. Recently, additional, more complex, roles for these receptors have been proposed because FPR, and to a greater extent FPRL1, have been found to interact with a menagerie of structurally diverse pro- and anti-inflammatory ligands associated with different diseases, including amyloidosis, Alzheimer's disease, prion disease and HIV. How these receptors recognize such diverse ligands, which are the most important in vivo, and how they contribute to disease pathogenesis and host defense are basic questions currently under investigation that could lead to new therapeutic targets.
Similar articles
-
Pleiotropic roles of formyl peptide receptors.Cytokine Growth Factor Rev. 2001 Mar;12(1):91-105. doi: 10.1016/s1359-6101(01)00003-x. Cytokine Growth Factor Rev. 2001. PMID: 11312121 Review.
-
A new insight into the role of "old" chemotactic peptide receptors FPR and FPRL1: down-regulation of chemokine receptors CCR5 and CXCR4.Forum (Genova). 1999 Oct-Dec;9(4):299-314. Forum (Genova). 1999. PMID: 10611407 Review.
-
Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation.J Immunol. 1999 Dec 15;163(12):6777-84. J Immunol. 1999. PMID: 10586077
-
Receptors for chemotactic formyl peptides as pharmacological targets.Int Immunopharmacol. 2002 Jan;2(1):1-13. doi: 10.1016/s1567-5769(01)00150-3. Int Immunopharmacol. 2002. PMID: 11789660 Review.
-
Molecular biology for formyl peptide receptors in human diseases.J Mol Med (Berl). 2013 Jul;91(7):781-9. doi: 10.1007/s00109-013-1005-5. Epub 2013 Feb 13. J Mol Med (Berl). 2013. PMID: 23404331 Review.
Cited by
-
Primary Immunodeficiencies With Defects in Innate Immunity: Focus on Orofacial Manifestations.Front Immunol. 2020 Jun 18;11:1065. doi: 10.3389/fimmu.2020.01065. eCollection 2020. Front Immunol. 2020. PMID: 32625202 Free PMC article. Review.
-
Up-regulation of Annexin-A1 and lipoxin A(4) in individuals with ulcerative colitis may promote mucosal homeostasis.PLoS One. 2012;7(6):e39244. doi: 10.1371/journal.pone.0039244. Epub 2012 Jun 18. PLoS One. 2012. PMID: 22723974 Free PMC article.
-
Antimicrobial peptide scolopendrasin VII, derived from the centipede Scolopendra subspinipes mutilans, stimulates macrophage chemotaxis via formyl peptide receptor 1.BMB Rep. 2015 Aug;48(8):479-84. doi: 10.5483/bmbrep.2015.48.8.115. BMB Rep. 2015. PMID: 26129676 Free PMC article.
-
Scant Extracellular NAD Cleaving Activity of Human Neutrophils is Down-Regulated by fMLP via FPRL1.Korean J Physiol Pharmacol. 2014 Dec;18(6):497-502. doi: 10.4196/kjpp.2014.18.6.497. Epub 2014 Dec 30. Korean J Physiol Pharmacol. 2014. PMID: 25598664 Free PMC article.
-
Controlling inflammation: a fat chance?J Exp Med. 2005 Mar 7;201(5):671-4. doi: 10.1084/jem.20050222. J Exp Med. 2005. PMID: 15753201 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases